AN2 Therapeutics Inc. (ANTX)
ANTX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.60
-16.28% on the day
Market cap
$135.9M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ANTX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2022 |
| SEC CIK | 0001880438 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-04-20 |
| Latest annual report | 10-K | 2026-03-17 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-08-11 |
| Latest proxy | DEFA14A | 2026-04-22 |
Source: SEC EDGAR submissions feed, 384 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc. | $0.9796 | -22.25% | $135.5M |
| TLSA | Tiziana Life Sciences Ltd. Common Shares | $1.09 | 0.00% | $138.7M |
| RNA | Atrium Therapeutics Inc. | $7.75 | -5.60% | $132.6M |
| BGM | BGM Group Ltd. | $10.48 | +2.75% | $140.0M |
| CUE | Cue Biopharma Inc. | $19.57 | -20.48% | $142.2M |
| KRRO | Korro Bio Inc. | $8.81 | -5.98% | $129.7M |
| OGI | Organigram Global Inc. Common Shares | $0.9190 | -1.68% | $129.6M |
| KZIA | Kazia Therapeutics Limited | $8.04 | -8.74% | $125.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier